Updated: January 26, 2026
How Does Linzess Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

Summarize with AI
Linzess works by activating GC-C receptors in your gut to increase fluid secretion. Here's a plain-English explanation of how linaclotide works and why it helps.
Linzess (linaclotide) belongs to a drug class called guanylate cyclase-C (GC-C) agonists. It works very differently from traditional laxatives—instead of drawing water into the bowel or stimulating muscle contractions, Linzess activates specific receptors on intestinal cells to produce its effects. Here's a plain-English explanation of exactly how it works.
The Short Answer: Linzess Mimics a Natural Gut Peptide
Your intestine naturally produces two peptides—guanylin and uroguanylin—that help regulate fluid balance in the gut. Linzess is a synthetic 14-amino acid peptide that mimics these natural compounds. When you take Linzess, it binds to the same receptor these natural peptides use: the guanylate cyclase-C (GC-C) receptor, located on the inner surface of intestinal cells.
Step-by-Step: How Linzess Relieves Constipation
- Linzess binds to GC-C receptors: After you swallow the capsule, the linaclotide compound passes into the small intestine, where it attaches to GC-C receptors on the surface (luminal side) of intestinal epithelial cells.
- cGMP production increases: Activating GC-C triggers the enzyme guanylate cyclase, which converts GTP into cyclic guanosine monophosphate (cGMP)—a chemical messenger inside the cell.
- Ions are secreted into the intestine: The elevated cGMP activates chloride and bicarbonate channels on the cell surface, causing these ions to flow from the cell into the intestinal lumen.
- Water follows the ions: Water passively moves from the intestinal cells into the intestinal lumen to balance the ion concentration. This increases the fluid content inside the intestine.
- Stools become softer and easier to pass: With more fluid in the intestine, stool is softened and lubricated. This makes bowel movements easier and more frequent.
- Gut transit speeds up: The increased fluid also stimulates faster movement of contents through the intestine, further reducing constipation.
How Linzess Relieves Abdominal Pain in IBS-C
One of the distinguishing features of Linzess compared to traditional laxatives is that it also helps reduce abdominal pain. Here's how:
The increased cGMP from GC-C activation doesn't just stay inside the intestinal cells—some of it leaks out into the space just below the cells (the subepithelial space), where pain-sensing nerves are located. This extracellular cGMP reduces the sensitivity of these nerves, lowering pain signals sent to the brain. This explains why IBS-C patients often experience improvement in abdominal pain and cramping in addition to relief from constipation.
Why Linzess Doesn't Enter Your Bloodstream
An important pharmacological fact about Linzess: it is negligibly absorbed into the bloodstream after oral administration. Linaclotide and its active metabolite work exclusively within the gut. They are broken down (proteolytically degraded) into smaller peptides and natural amino acids right in the intestinal lumen.
This local action explains why Linzess:
- Has virtually no drug-drug interactions (doesn't affect the liver's CYP450 enzyme system)
- Is unlikely to affect a developing fetus or breastfed infant (maternal use is not expected to result in fetal or infant exposure)
- Does not cause systemic (whole-body) side effects—all side effects are GI-related
How Is Linzess Different From Laxatives?
Traditional laxatives work through different mechanisms:
- Osmotic laxatives (e.g., MiraLAX/polyethylene glycol): Draw water into the colon via osmosis
- Stimulant laxatives (e.g., senna, bisacodyl): Directly stimulate intestinal muscle contractions
- Bulk-forming laxatives (e.g., psyllium/Metamucil): Absorb water to add bulk and soften stool
Linzess, by contrast, works at the receptor level to trigger the body's own fluid-secretion mechanisms. This receptor-level approach is why it's particularly effective for IBS-C, where both constipation and abdominal pain need to be addressed simultaneously.
The Bottom Line
Linzess is a targeted, locally-acting medication that works through a receptor-based mechanism distinct from any over-the-counter laxative. Its ability to address both constipation and abdominal pain makes it particularly valuable for IBS-C. For more information about uses and dosage, read our guide on what Linzess is and how it's used.
Frequently Asked Questions
Linzess (linaclotide) binds to guanylate cyclase-C (GC-C) receptors on the inner surface of intestinal cells. This triggers the production of cGMP, which causes chloride and bicarbonate ions to be secreted into the intestine. Water follows these ions, increasing intestinal fluid. The result is softer stools, faster bowel transit, and reduced abdominal pain signaling.
No. Linzess (linaclotide) is negligibly absorbed into the bloodstream after oral administration. It works exclusively within the gut and is broken down into small peptides and amino acids in the intestinal lumen. This local action means it has virtually no drug-drug interactions and does not affect other organs.
Linzess works at the receptor level—activating GC-C receptors to trigger the body's own fluid-secretion mechanisms. MiraLAX (polyethylene glycol) is an osmotic laxative that draws water into the colon passively. Unlike laxatives, Linzess also reduces visceral pain signaling, making it effective for IBS-C where abdominal pain is a primary symptom.
Diarrhea is a direct extension of Linzess's mechanism. By increasing fluid secretion and speeding gut transit, Linzess can push the bowel beyond the intended effect—especially at higher doses—resulting in loose or watery stools. The 290 mcg dose (used for IBS-C) is more likely to cause diarrhea than the 72 or 145 mcg doses.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Linzess also looked for:
More about Linzess
37,283 have already found their meds with Medfinder.
Start your search today.





